bpc 157 inflammatory bowel disease human study Stable gastric pentadecapeptide in the treatment of colitis and ischemia and reperfusion in rats: New insights The Stable Gastric Pentadecapeptide BPC

[DOI] [PMC free article] [PubMed] [Google Scholar] 148.Sanchez, L., Wang, Y., Siegel, D

2012, p

The Evidence: Research indicates that PEMF therapy can reduce the frequency and severity of migraine attacks by modulating the autonomic nervous system and reducing inflammation [6]

That Anti-LOX (30.50 0.65 mm), HCG (28.83 0.69 mm), VED (30.75 0.25 mm), Anti-LOX + VED (33.42 0.89 mm), HCG + VED (31.17 1.55 mm), and Anti-LOX + HCG + VED (33.25 0.80 mm) significantly increased exposed length ( p 0.05) but significantly shorter than Anti-LOX ( p 0.05)

This makes it a powerful appetite-regulating compound with enhanced metabolic signalling compared to GLP-1 alone

For this reason, BPC-157 peptide therapy is useful in the treatment of ulcers, esophageal irritation, and symptoms of inflammatory bowel disease